3D-CONFORMAL RADIATION THERAPY (CRT) PLUS STEREOTACTIC BOOST (SRT) AND CONCOMITANT TEMOZOLOMIDE IN HIGH GRADE GLIOMAS (HGG): FINAL REPORT

被引：0
|
作者：
Apicella, G. [1 ]
Balducci, M. [1 ]
Anile, C. [2 ]
Manfrida, S. [1 ]
Dinapoli, N. [1 ]
D'Agostino, G. R. [1 ]
Azario, L. [3 ]
Mantini, G. [1 ]
Frascino, V. [1 ]
Fiorentino, A. [1 ]
Mangiola, A. [2 ]
Valentini, V. [1 ]
机构：
[1] Policl Univ A Gemelli, Radiat Oncol, Rome, Italy
[2] Policl Univ A Gemelli, Inst Neurosurg, Rome, Italy
[3] Policl Univ A Gemelli, Dept Phys, Rome, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
632
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [31] Dose escalation with high-dose 3D-conformal radiotherapy (HD-3D-CRT) or low-dose 3D-conformal radiotherapy plus HDR brachytherapy (LD-3D-CRT+HDR-B) for intermediate-or high-risk prostate cancer: Higher PSA control with lower toxicity
    Guix, B.
    Bartrina, J.
    Tello, J.
    Lacorte, T.
    Henriquez, I.
    Sole, J.
    Guix, I.
    Galdon, G.
    Espino, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [32] TREATMENT OF INTERMEDIATE-OR HIGH-RISK PROSTATE CANCER BY DOSE ESCALATION WITH HIGH-DOSE 3D-CONFORMAL RADIOTHERAPY (HD-3D-CRT) OR LOW-DOSE 3D-CONFORMAL RADIOTHERAPY PLUS HDR BRACHYTHERAPY (LD-3D-CRT+HDR-B) : EARLY RESULTS OF A PROSPECTIVE COMPARATIVE TRIAL
    Guix, B.
    Bartrina, J. M.
    Tello, J. I.
    Sole, J.
    Quinzanos, L.
    Lacorte, T.
    Leon, F.
    Fernandez, J.
    Henriquez, I.
    Guix, I.
    Galdon, G.
    Espino, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S418 - S418
  • [33] Dose of Hypo-fractionated Stereotactic Radiation Therapy, but not Repeat Craniotomy or Concomitant Chemotherapy is Associated with Improved Survival in Recurrent High Grade Gliomas
    Fogh, S. E.
    Glass, C.
    Champ, C.
    Andrews, D. W.
    Hyslop, T.
    Dicker, A. P.
    Werner-Wasik, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S234 - S234
  • [34] Treatment of intermediate- or high-risk prostate cancer by dose escalation with high-dose 3D-conformal radiotherapy (HD-3D-CRT) or low-dose 3D-conformal radiotherapy plus HDR brachytherapy (LD-3D-CRT+HDR-B): Early results of a prospective comparative trial
    Guix, B.
    Bartrina, J.
    Tello, J.
    Quinzanos, L.
    Sole, J.
    Lacorte, T.
    Fernandez, J.
    Goix, I.
    Galdon, G.
    Espino, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Treatment of Intermediate-or High-risk Prostate Cancer by Dose Escalation with High-dose 3D-conformal Radiotherapy (HD-3D-CRT) or Low-dose 3D-conformal Radiotherapy Plus HDR Brachytherapy (LD-3D-CRT+HDR-B): Early Results of a Prospective Comparative Trial
    Guix, B.
    Bartrina, J.
    Tello, J.
    Sole, J.
    Quinzanos, L.
    Lacorte, T.
    Fernandez, J.
    Leon, C.
    Guix, I.
    Galdon, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S78 - S78
  • [36] Comparison of radiation proctitis of prostate cancer treated by 3-dimensional conformal radiotherapy (3D-CRT) alone and 3D-CRT plus high dose rate implant
    Wang, Y.
    Fang, F.
    Chiang, P.
    Wang, C.
    Chen, H.
    Hsu, H.
    Huang, E.
    Hsiung, C.
    Wang, C.
    Huang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S394 - S394
  • [37] A PHASE I STUDY OF RIBOCICLIB AND EVEROLIMUS FOLLOWING RADIATION THERAPY IN CHILDREN WITH NEWLY DIAGNOSED NON-BIOPSIED DIFFUSE PONTINE GLIOMAS (DIPG) AND RB plus BIOPSIED DIPG AND HIGH GRADE GLIOMAS (HGG)
    DeWire, Mariko
    Leach, James
    Fuller, Christine
    de Blank, Peter
    Hummel, Trent
    Pillay-Smiley, Natasha
    Salloum, Ralph
    Stevenson, Charles
    Drissi, Rachid
    Kumar, Shiva Senthil
    Baxter, Patricia
    Gass, David
    Goldman, Stewart
    Leary, Sarah
    Lane, Adam
    Campagne, Olivia
    Stewart, Clinton
    Fouladi, Maryam
    NEURO-ONCOLOGY, 2020, 22 : 307 - 307
  • [38] Single-Arm Phase II Study of Conformal Radiation Therapy and Temozolomide plus Fractionated Stereotactic Conformal Boost in High-Grade GliomasFinal ReportEinarmige Phase-II-Studie zur konformalen Strahlentherapie mit Temozolomid plus fraktionierter stereotaktischer konformaler Boostbestrahlung bei höhergradigen Gliomen. Abschlussbericht
    Mario Balducci
    Giuseppina Apicella
    Stefania Manfrida
    Annunziato Mangiola
    Alba Fiorentino
    Luigi Azario
    Giuseppe Roberto D’Agostino
    Vincenzo Frascino
    Nicola Dinapoli
    Giovanna Mantini
    Alessio Albanese
    Pasquale de Bonis
    Silvia Chiesa
    Vincenzo Valentini
    Carmelo Anile
    Numa Cellini
    Strahlentherapie und Onkologie, 2010, 186 : 558 - 564
  • [39] Dose escalation with high-dose-3D-conformal (HD-3D-CRT) or low-dose 3D-conformal radiotherapy PLUS HDR brachytherapy (LD-3D-CRT+HDR-B) for intermediate- or high-risk prostate cancer: Higher disease control and survival with lower toxicity.
    Guix, Benjamin
    Maria Bartrina, Jose
    Ignacio Tello, Jose
    Quinzanos, Luis
    Maria Lacorte, Teresa
    Guix, Ines
    Galdon, Guillermo
    Espino, Marc
    Guix, Teresa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] High-dose 3D-Conformal Radiation Therapy (CRT): a new curative treatment for patients with small hepatocellular carcinomas (HCC). Mature results of a French phase II trial (RTF1)
    Mornex, F.
    Wautot, V.
    Kubas, A.
    Serres, A.
    Maillard, E.
    Trepo, C.
    Merle, P.
    EJC SUPPLEMENTS, 2007, 5 (04): : 271 - 271
12345